🟢 HCW Biologics is trading 7.5% up today as it rebounds from recent volatility on light news flow

HCW Biologics is trading at $2.78 (7.5%) up today, rebounding modestly from recent volatility and sharp declines seen last week.

• There are no fresh company-specific headlines or earnings releases after the July 28 close; the move likely reflects thin after-hours liquidity.
• The price action suggests trader repositioning around the company's cancer pipeline news originally released on July 27.
• A generally constructive broader market backdrop is providing additional support for the rebound.